Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

Open Clinical Trials

We are committed to advancing hemophilia patient care and facilitating the development of novel treatments through research studies and clinical trials. The development of new strategies, including disease-modifying and curative therapies, form the basis of our progressive approach to hemophilia management for patients at Weill Cornell Medicine.

Diseases:
Blood Disorders | Non-Malignant/Benign Hematology, Hemophilia, Hemophilia B
Location(s):
Upper East Side - Manhattan
Primary Investigator(s):
Catherine McGuinn, MD
Diseases:
Bleeding and Platelet Disorders, Hemophilia, Hemophilia A
Location(s):
Upper East Side - Manhattan
Primary Investigator(s):
Catherine McGuinn, MD
Diseases:
Hemophilia
Location(s):
Upper East Side - Manhattan
Primary Investigator(s):
Catherine McGuinn, MD
Diseases:
Hemophilia B
Location(s):
Upper East Side - Manhattan
Primary Investigator(s):
Catherine McGuinn, MD

Weill Cornell Medicine Comprehensive Hemophilia Treatment Center 525 East 68th Street
Payson 695
New York, NY 10065 Phone: (212) 746-3421 Fax: (212) 746-8609